CHICAGO (Reuters) - Medtronic Inc has sent a letter to physicians warning about possible reduced battery performance in a small percentage of its SynchroMed II Implantable Drug Infusion Pumps, the ...
Medtronic’s SynchroMed II implantable drug pump device, which has been recalled three times in recent years and tied to 14 deaths, has continued to be problematic for the medtech company. A three-page ...
Kessler pilot study shows pump delivery system unaffected although interference with communication may occur during the pump’s log transmission The pilot study was conducted at the Tim and Caroline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback